Enteral and Parenteral Medical Nutrition Market Scope 2031
The enteral and parenteral medical nutrition market size is projected to reach US$ 32,408.02 million by 2031 from US$ 18,377.13 million in 2023. The market is expected to register a CAGR of 7.3% during 2023–2031. Specific formulations and plant-based nutritional products are likely to serve as key trends in the market.
Enteral and Parenteral Medical Nutrition Market Analysis
The growth of the market is mainly fueled by the growing investments from international players, improving government support in countries such as China, supportive initiatives and nutrition research, and advancing healthcare infrastructure. The macro and micronutrient formulations of enteral and parenteral nutrition and their applications vary based on different diseases, such as cancer and gastrointestinal diseases. Energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction. A rise in the number of people turning to plant-based food causes the demand for plant-based nutrition products worldwide. The Innova Consumer Survey 2020 revealed that diet variety, health, sustainability, and taste are among the most important reasons why people consider plant-based alternatives. Companies (Kate Farms, Functional Formularies, and Real Food Blends) in the market anticipate that a rising focus on healthy foods will change into a preference for healthier nutrition products. As a result, companies have developed more natural and plant-based enteral products. Moreover, the rising geriatric population, growing incidence of chronic diseases and neurological disorders, and product innovations by the market players are anticipated to support the market growth.
Enteral and Parenteral Medical Nutrition Market Overview
According to the Centers for Disease Control and Prevention (CDC) data, preterm birth in the US accounted for 10% of all births in 2020 and reached 10.5% in 2021, recording a yearly rise of 4%. According to the July 2022 data of the United Nations International Children's Emergency Fund, the prevalence of undernourishment increased 9.3% in 2020 from 8.0% in 2019; it again jumped to 9.8% in 2021. Similarly, as per a study titled “A multi-center survey on hospital malnutrition,” published in 2021, about 33% of patients in US hospitals were either malnourished or at nutritional risk, and approximately 11–45% of hospital patients and home care settings patients in England suffered from malnutrition. Thus, the enormous burden of malnutrition in children and adults, along with a high number of preterm births, fuels the demand for enteral and parenteral medical nutrition products, which in turn stimulates the growth of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Enteral and Parenteral Medical Nutrition Market: Strategic Insights
Market Size Value in US$ 17,343.46 million in 2022 Market Size Value by US$ 25,476.86 million by 2028 Growth rate CAGR of 6.8% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Enteral and Parenteral Medical Nutrition Market: Strategic Insights
| Market Size Value in | US$ 17,343.46 million in 2022 |
| Market Size Value by | US$ 25,476.86 million by 2028 |
| Growth rate | CAGR of 6.8% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Enteral and Parenteral Medical Nutrition Market Drivers and Opportunities
Rising Number of Gastrointestinal Diseases to Favor Market Growth
Bowel obstruction, Crohn’s disease, ulcerative colitis, short bowel syndrome (SBS), and certain cancers are some examples of gastrointestinal diseases. As per the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected more than 40% of people across the world. Research conducted by Crohn’s & Colitis UK confirms that ~1 in every 123 people in the country had either Crohn’s disease or ulcerative colitis in 2022, accounting for ~0.5 million people living with IBD in the UK. Moreover, SBS occurs in ~3 per 1 million people yearly. Patients with gastrointestinal diseases are at an increased risk of nutritional degradation. They may also experience nutritional deterioration due to therapeutic dietary limitation and loss of appetite caused by anorexia or altered nutritional requirements, which can be due to the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. The enteral and parenteral routes are ideal to provide them with essential nutrients. Therefore, the rising cases of gastrointestinal diseases drive the growth of the enteral and parenteral medical nutrition market.
Growing Strategic Initiatives by Companies
Companies operating in the enteral and parenteral medical nutrition market continuously focus on strategic developments, which help them advance their sales, enlarge their geographic reach, and improve their capacities to cater to a greater than existing customer base. Some of the noteworthy developments in the market are mentioned below:
- In January 2023, Nutricia introduced Fortimel Plant-Based Energy, which is the first plant-based, ready-to-drink oral nutritional supplement. The product is particularly designed to fulfill the nutritional needs of malnourished individuals or individuals at risk of malnutrition due to illness. With this launch, the company builds on Danone's (parent company) capability in plant nutrition to grow its Fortimel portfolio.
- In March 2022, Vygon acquired Macatt Medica (a distribution company located in Peru). Macatt Medica delivers most of Vygon’s products in Peru, including a variety of enteral nutrition products. With the acquisition, Macatt Medica became an entirely owned subsidiary of Vygon, assisting the latter's operations in South America.
Therefore, the development of advanced products targeting numerous health issues and strategic moves allow companies in the market to create new or better products and new businesses to remain competitive in the market. Such strategic growth initiatives provide significant growth opportunities in the market.
Enteral and Parenteral Medical Nutrition Market Report Segmentation Analysis
Key segments that contributed to the derivation of the enteral and parenteral medical nutrition market analysis are indication, nutrition type, form, product type, route of administration, age group, and distribution channel.
- Based on indication, the enteral and parenteral medical nutrition market is divided into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, renal disease, liver failure, Alzheimer’s disease, dementia, post-COVID-19, and others. The elderly segment held the largest share of the market in 2023. The gastrointestinal disorders segment is anticipated to register the highest CAGR during the forecast period.
- By nutrition type, the market is bifurcated into supplemental and sole source. The supplemental segment held a larger share of the market in 2023. The sole source segment is projected to register a higher CAGR during the forecast period.
- Based on form, the enteral and parenteral medical nutrition market is categorized into liquid, powder, and semi-solid. The liquid segment held the largest market share in 2023. The powder segment is anticipated to register the highest CAGR during the forecast period.
- By product type, the market is segmented into general and disease-specific. The general segment held a larger share of the market in 2023 and is projected to register a higher CAGR during the forecast period.
- Based on the route of administration, the market is categorized into oral, tube feed, and parenteral. The parenteral segment held the largest share of the market in 2023. The oral segment is estimated to register the highest CAGR during the forecast period.
- By age group, the market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60-year segment held the largest market share in 2023. The 18-60 years segment is projected to register the highest CAGR during the forecast period.
- By distribution channel, the market is divided into hospital pharmacies, e-commerce, retail stores, and others. The hospital pharmacies segment held the largest share of the market in 2023. The e-commerce segment is anticipated to register the highest CAGR during the forecast period.
Enteral and Parenteral Medical Nutrition Market Share Analysis by Geography
The geographic scope of the enteral and parenteral medical nutrition market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the enteral and parenteral medical nutrition market. The growth of the market in this region is attributed to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral and parenteral nutrition, as well as an upsurge in knowledge among individuals about the benefits of medical nutrition. According to an article titled “Trends in Parenteral Nutrition,” on average, ~34,000 patients receive parenteral nutrition annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children. In addition, the US government is taking several initiatives to boost the enteral and parenteral medical nutrition market. For instance, the Feeding Tube Awareness Foundation is creating awareness about adopting feeding tubes and the benefits associated with them. The Canadian Digestive Health Foundation states millions of Canadians live with digestive disease. ~20 million Canadians, i.e., two of every three people, suffer from digestive disorders yearly.
Furthermore, the presence of major market players is likely to have a positive effect on the growth of the enteral and parenteral medical nutrition market in the coming years. In February 2021, Amsino Medical Group received the FDA 510(k) clearance for its Puggle enteral feeding pump and feeding set for pediatric and adult patients. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
Enteral and Parenteral Medical Nutrition Market Report Scope
Enteral and Parenteral Medical Nutrition Market News and Recent Developments
The enteral and parenteral medical nutrition market is evaluated by gathering qualitative and quantitative data post post-post-primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the enteral and parenteral medical nutrition market are listed below:
- Fresenius Kabi’s SMOFlipid lipid injectable emulsion received US Food and Drug Administration (FDA) approval. The emulsion is used to provide parenteral nutrition to pediatric patients, including term and preterm neonates, which makes it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age. (Source: Fresenius Kabi, Press Release, March 2022)
- Abbott launched Similac 360 Total Care, the company's next generation of infant formula with human milk oligosaccharides (HMO). It is the first and only infant formula in the US with a blend of five various prebiotic HMOs (only found together in breast milk). Similac 360 Total Care is developed to provide nutrition to support whole health and progress in babies, including the development of the immune system, digestive system, and brain. (Source: Abbott, Press Release, November 2021)
Enteral and Parenteral Medical Nutrition Market Report Coverage and Deliverables
The “Enteral and Parenteral Medical Nutrition Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Enteral and parenteral medical nutrition market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Enteral and parenteral medical nutrition market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Enteral and parenteral medical nutrition market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the enteral and parenteral medical nutrition market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Indication, Nutrition Type, Product Type, Route of Administration, Age Group, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Egypt, France, Germany, India, Indonesia, Iran, Israel, Italy, Japan, Mexico, Netherlands, Peru, Poland, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom, United States, Vietnam
Frequently Asked Questions
North America region dominated the enteral and parenteral medical nutrition market in 2023.
The increase in the prevalence of gastrointestinal diseases and growing cases of malnutrition and premature births are the most influential factors responsible for market growth.
Abbott Laboratories, Nestle SA, Nutricia International BV, Medtrition Inc, Fresenius Kabi AG, B. Braun SE, Smartfish AS, Nutrisens SAS, AYMES International Ltd, Medifood International SA, Easy Line Ltd, Charing Cross Scientific AS, Baxter International Inc, and Medica Nutrition Inc. are the market players in the enteral and parenteral medical nutrition market.
The estimated value of the enteral and parenteral medical nutrition market accounted for US$ 32,408.02 million in 2031.
The global enteral and parenteral medical nutrition market is estimated to register a CAGR of 7.3% during the forecast period 2023–2031.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Enteral and Parenteral Medical Nutrition Market
Aug 2024
Infectious Diasease Therapeutics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti Bacterial, Anti-Fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Aug 2024
Clinic Casting and Splinting Products Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product [Casting (Casts, Tapes, Cutters, and Casting Accessories) and Splinting (Splints and Splinting Accessories)], Application (Acute Fractures or Sprains, Tendon and Ligament Injuries, and Others), Material (Plaster of Paris, Fiberglass, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2024
Myopia Treatment Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (High Myopia, Degenerative Myopia, Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Ortho-K, Contact Lenses, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers), and Geography
Aug 2024
Epilepsy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Aug 2024
Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography
Aug 2024
Human Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography
Aug 2024
Epilepsy Drugs Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (First-Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Aug 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For